DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Poplin E, Feng Y, Berlin J. et al.
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
J Clin Oncol 2009; 27: 3778-3785
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.